1. 1. Bateman, K. E., Catton, P. A., Pennock, P. W. and Kruth, S. A. 1994. 0-7-21 radiation therapy for the treatment of canine oral melanoma. J. Vet. Intern. Med. 8: 267–272.
2. 2. Bergman, P. J., Camps-Palau, M. A., McKnight, J. A., Leibman, N. F., Craft, D. M., Leung, C., Liao, J., Riviere, I., Sadelain, M., Hohenhaus, A. E., Gregor, P., Houghton, A. N., Perales, M. A. and Wolchok, J. D. 2006. Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center. Vaccine 24: 4582–4585.
3. 3. Bergman, P. J., McKnight, J., Novosad, A., Charney, S., Farrelly, J., Craft, D., Wulderk, M., Jeffers, Y., Sadelain, M., Hohenhaus, A. E., Segal, N., Gregor, P., Engelhorn, M., Riviere, I., Houghton, A. N. and Wolchok, J. D. 2003. Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial. Clin. Cancer Res. 9: 1284–1290.
4. 4. Blackwood, L. and Dobson, J. M. 1996. Radiotherapy of oral malignant melanomas in dogs. J. Am. Vet. Med. Assoc. 209: 98–102.
5. 5. Boria, P. A., Murry, D. J., Bennett, P. F., Glickman, N. W., Snyder, P. W., Merkel, B. L., Schlittler, D. L., Mutsaers, A. J., Thomas, R. M. and Knapp, D. W. 2004. Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogs. J. Am. Vet. Med. Assoc. 224: 388–394.